Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.
Salvarani C, Bajocchi G, Mancuso P, Galli E, Muratore F, Boiardi L, Catanoso M, Pipitone N, Cassone G, Girolimetto N, Croci S, Cimino L, Gradellini F, Beltrami M, Di Lernia V, Dolci G, Massari M, Marata AM, Costantini M, Giorgi Rossi P. Salvarani C, et al. Among authors: di lernia v. Ann Rheum Dis. 2020 Jul;79(7):986-988. doi: 10.1136/annrheumdis-2020-217903. Epub 2020 May 28. Ann Rheum Dis. 2020. PMID: 32467245 No abstract available.
Management of Nail Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
Laheru D, Antony A, Carneiro S, Di Lernia V, Garg A, Love TJ, Del Rocio Macias Garcia K, Mendonça JA, Mukherjee S, Olteanu R, Perez-Chada L, Rosen CF, Tannenbaum R, Yazbek MA. Laheru D, et al. Among authors: di lernia v. J Rheumatol. 2023 Mar;50(3):433-437. doi: 10.3899/jrheum.220313. Epub 2022 Nov 1. J Rheumatol. 2023. PMID: 36319021 Free article.
Adalimumab in psoriatic arthritis.
Salvarani C, Pipitone N, Catanoso M, Chiarolanza I, Boiardi L, Caruso A, Pazzola G, Macchioni P, Di Lernia V, Albertini G. Salvarani C, et al. Among authors: di lernia v. J Rheumatol Suppl. 2012 Jul;89:77-81. doi: 10.3899/jrheum.120251. J Rheumatol Suppl. 2012. PMID: 22751600 Review.
COVID-19 in an elderly patient treated with secukinumab.
Di Lernia V, Bombonato C, Motolese A. Di Lernia V, et al. Dermatol Ther. 2020 Jul;33(4):e13580. doi: 10.1111/dth.13580. Epub 2020 May 27. Dermatol Ther. 2020. PMID: 32406078 No abstract available.
Antipsoriatic treatments during COVID-19 outbreak.
Di Lernia V. Di Lernia V. Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10. Dermatol Ther. 2020. PMID: 32223073 Free PMC article. No abstract available.
Reply: "Biologics for psoriasis during COVID-19 outbreak".
Di Lernia V. Di Lernia V. J Am Acad Dermatol. 2020 Jun;82(6):e217-e218. doi: 10.1016/j.jaad.2020.04.004. Epub 2020 Apr 10. J Am Acad Dermatol. 2020. PMID: 32283234 Free PMC article. No abstract available.
177 results